Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Gauthier

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Blood Advances|January 19, 2018
Successful treatment with fingolimod of graft-versus-host disease of the central nervous systemJordan Gauthier, Patrick Vermersch, Paul Chauvet, et al.
Journal of Hematopathology|August 26, 2024
Complete loss of lineage defining antigens in two cases of B-cell malignancies following CAR-T therapyAlireza Torabi, Jason Love, Teresa Hyun, et al.
Current Research in Translational Medicine|October 22, 2019
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host diseaseTamim Alsuliman, Leonardo Magro, Valerie Coiteux, et al.
Blood|November 24, 2025
Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR dataRahul Banerjee, Christy Khouderchah, Othman Salim Akhtar, et al.
Movement Disorders Clinical Practice|November 19, 2025
Treatment-Emergent Parkinsonism in Four Patients Treated with Chimeric Antigen Receptor T-Cell TherapyJohn B Sanderson, Yi-Han Lin, Kimmy Su, et al.
Blood Advances|October 8, 2020
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapyVictor A Chow, Ajay K Gopal, Jordan Gauthier, et al.
Bone Marrow Transplantation|September 5, 2019
Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myelomaSalvatore Fiorenza, David Routledge, Jenny Collins, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Bone Marrow Transplantation|December 27, 2022
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic reviewAndrew J Portuguese, Jordan Gauthier, Scott S Tykodi, et al.
Transplantation and Cellular Therapy|November 8, 2025
A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy ResearchHéctor A Vaquera-Alfaro, Yein Jeon, Qian Vicky Wu, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Blood Advances|January 19, 2018
Successful treatment with fingolimod of graft-versus-host disease of the central nervous systemJordan Gauthier, Patrick Vermersch, Paul Chauvet, et al.
Journal of Hematopathology|August 26, 2024
Complete loss of lineage defining antigens in two cases of B-cell malignancies following CAR-T therapyAlireza Torabi, Jason Love, Teresa Hyun, et al.
Current Research in Translational Medicine|October 22, 2019
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host diseaseTamim Alsuliman, Leonardo Magro, Valerie Coiteux, et al.
Blood|November 24, 2025
Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR dataRahul Banerjee, Christy Khouderchah, Othman Salim Akhtar, et al.
Movement Disorders Clinical Practice|November 19, 2025
Treatment-Emergent Parkinsonism in Four Patients Treated with Chimeric Antigen Receptor T-Cell TherapyJohn B Sanderson, Yi-Han Lin, Kimmy Su, et al.
Blood Advances|October 8, 2020
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapyVictor A Chow, Ajay K Gopal, Jordan Gauthier, et al.
Bone Marrow Transplantation|September 5, 2019
Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myelomaSalvatore Fiorenza, David Routledge, Jenny Collins, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Bone Marrow Transplantation|December 27, 2022
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic reviewAndrew J Portuguese, Jordan Gauthier, Scott S Tykodi, et al.
Transplantation and Cellular Therapy|November 8, 2025
A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy ResearchHéctor A Vaquera-Alfaro, Yein Jeon, Qian Vicky Wu, et al.
Pageof 9